Lipitor Articles
Court deliberates Apotex' Plavix launch
28 August 2006
Pfizer's Lipitor lowers risk of second stroke
14 August 2006
Pfizer defends one Lipitor patent case, but loses second
7 August 2006
Pfizer
31 July 2006
'Statins could slow AAA growth,' US researchers
24 July 2006
US Senate OKs Rx drug imports from Canada
17 July 2006
Authorized generics 'increase competition'
10 July 2006
UK Appeals Court affirms earlier ruling
10 July 2006
Pfizer: Lipitor "cheaper" than generic Zocor
22 May 2006
Pfizer responds to Austrian Lipitor ruling
1 May 2006
Aging population's higher drug sales
1 May 2006
Retail drug sales up 5% in 2005
10 April 2006
Crestor better than Lipitor in Hispanics
3 April 2006
Japan's pharma licks its wounds after NHI cuts
13 March 2006
India's "big pharma" is now the target
27 February 2006
Pfizer wins Ranbaxy Lipitor injunction
27 February 2006
Statins account for 81% of first-line dyslipidemia treatment
30 January 2006
Stock Commentary - Europe - week to Jan 9
16 January 2006
Stock Commentary - Europe - week to Jan 9
9 January 2006
Stock Commentary - New York week to Jan 9
9 January 2006
Licensing pivotal to pharma industry evolving strategies
19 December 2005
US Patent Office to OK Pfizer Lipitor patent
5 December 2005
Spanish courts to hear Lipitor law suits
5 December 2005
Pfizer Germany sees 2006 recovery
12 September 2005
Sankyo's 1st-qtr sales and earnings dip
22 August 2005
NZ: lifetime Special Authority for Lipitor users
22 August 2005
Australian pharma warns over patent losses
22 August 2005
USA
22 August 2005
Generics firms taking more aggressive stance, says report
15 August 2005
Australia: no PBS price cut for Lipitor
25 July 2005
Pfizer's good results for higher-dose Lipitor
27 June 2005
Japan stock market week to June 20
27 June 2005
Astellas: merger costs cause 75% profit drop
30 May 2005
Nymox heralds new data for statins in AD
23 May 2005
S-P/Merck & Co
27 April 2005
AstraZeneca's Crestor 5mg available in EU
25 April 2005
US court upholds Lilly's Zyprexa patent
25 April 2005
Stock Commentary - Europe
18 April 2005
UPDATE: Pfizer's $4B cost-saving plan pleases investors, despite lower 2005 EPS forecast
11 April 2005
World retail Rx sales up 6% in 12 mnths to Jan
4 April 2005
Good and bad news for Pfizer on patents
4 April 2005
Japan stock market week to March 21
28 March 2005
Lipitor cuts risk of heart attack and stroke
21 March 2005
Vytorin beats Lipitor in high-risk patients
21 March 2005
Crestor: 21% cut in CRP in African-Americans
14 March 2005
FDA clears Crestor's labelling revision
7 March 2005
Strong nine months for Yamanouchi
28 February 2005
Ranbaxy profit down despite sales hike
31 January 2005
Retail drug prices up 7% in year to Nov 2004
24 January 2005
Norvasc combi therapy for hypertension
20 December 2004
Yamanouchi overcomes drug pric cuts
22 November 2004
Aspirations of Astellas Pharma, the merged Yamanouchi/Fujisawa
22 November 2004
Pfizer "no" to Lipitor price cut in Germany
15 November 2004
World Rx sales up 7% in year to September
15 November 2004
New Data confirm benefits of AstraZeneca's Crestor in treating broad range of patients
1 November 2004
World drug sales up 8% in year to August 2004
25 October 2004
Statins to open door for more US OTC switches?
20 September 2004
Editor's views on AstaZeneca Exanta woes and Bayer/S-P deal
20 September 2004
Pfizer suing 18 Internet sites selling illegal copies of Lipitor
13 September 2004
Disappointing new data for Merck & Co's Zocor in patients with ACS
6 September 2004
Tokyo pharma stocks - 2 weeks to August 30
6 September 2004
Global Rx drug prices up 8% in year to June 2004
23 August 2004
3% underlying sales rise at Yamanouchi
23 August 2004
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
